Search Count: 55
 |
Crystal Structure Of Irak4-Hsa Complexed With N-[(2R)-2-Fluoro-3-Hydroxy-3-Methylbutyl]-6-[(5-Fluoropyri-Yl)Amino]-4-[(Propan-2-Yl)Amino]Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-02-12 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ZVD, SO4 |
 |
Crystal Structure Of Irak4-Hsa Complexed With Bms-986126; 6-((5-Cyano-2-Pyrimidinyl)Amino)-N-((2R)-2-Fluoro-3-Hydroxhylbutyl)-4-(Isopropylamino)Nicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2025-02-12 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ZVG, SO4 |
 |
Crystal Structure Of Irak4-Hsa Complexed With Bms-986147; 6-{5-Cyano-1H-Pyrazolo[3,4-B]Pyridin-1-Yl}-N-[(2R)-2-Fluorroxy-3-Methylbutyl]-4-[(Propan-2-Yl)Amino]Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.76 Å Release Date: 2025-02-12 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: SO4, ZVA |
 |
Crystal Structure Of Farnesoid X-Activated Receptor Complexed With Compound-32 Aka (1S,3S)-N-({4-[5-(2-Fluoropr Opan-2-Yl)-1,2,4-Oxadiazol-3-Yl]Bicyclo[2.2.2]Octan-1-Yl}M Ethyl)-3-Hydroxy-N-[4'-(2-Hydroxypropan-2-Yl)-[1,1'-Biphen Yl]-3-Yl]-3-(Trifluoromethyl)Cyclobutane-1-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2022-06-29 Classification: NUCLEAR PROTEIN Ligands: IUS |
 |
Crystal Structure Of Ap2 Associated Kinase 1 Isoform 1 Complexed With Ligand (2R)-2-Amino-N-[3-(Difluorom Ethoxy)-4-(1,3-Oxazol-5-Yl)Phenyl]-4-Methylpentanamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2022-02-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: YFV, SO4, 5OI |
 |
Crystal Structure Of Ap2 Associated Kinase 1 Isoform 1 Complexed With Ligand 2-(1-Amino-3-Methylbutyl)-6- (Pyridin-4-Yl)Quinoline-4-Carbonitrile
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2022-02-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5P6, SO4 |
 |
Crystal Structure Of Ap2 Associated Kinase 1 Isoform 1 Complexed With Ligand (2R)-2-Amino-N-[3-(Difluorom Ethoxy)-4-(1,3-Oxazol-5-Yl)Phenyl]-4-Methylpentanamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2022-02-23 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5QI, PG6, SO4, YFV |
 |
Crystal Structure Of Ap2 Associated Kinase 1 Isoform 1 Complexed With Ligand N-[3-Methoxy-4-(1,3-Oxazol-5-Yl)Phenyl]-3-(Propan-2-Yl)Piperidine-2-Carboxamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2021-07-28 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: YFS, SO4, YFV |
 |
Crystal Structure Of Ap2 Associated Kinase 1 Isoform 1 Complexed With Ligand (2R)-2-Amino-N-[3-Methoxy-4- (1,3-Oxazol-5-Yl)Phenyl]-4-Methylpentanamide
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-07-28 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: YFY, SO4, YFV |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2020-11-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: EXF, SO4 |
 |
Crystal Structure Of Interleukin-1 Receptor-Associated Kinase 4 (Irak4-Wt) Complex With A Nicotinamide Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2020-06-24 Classification: TRANSFERASE/TRANSFERASE Inhibitor Ligands: R7S, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2016-05-11 Classification: TRANSFERASE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU, GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) In Complex With Staurosporine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU, GOL |
 |
Tgf-Beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A,R495A) In Complex With Staurosporine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With 3-Amino-6-[4-(2-Hydroxyethyl)Phenyl]-N-[4-(Morpholin-4-Yl)Pyridin-3-Yl]Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5L4 |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) In Complex With 3-Amino-6- [4-(2-Hydroxyethyl)Phenyl]-N-[4-(Morpholin-4-Yl)Pyridin-3-Yl]Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5L4 |